Your browser doesn't support javascript.
loading
Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort.
Liu, Xiaoran; Li, Huiping; Shao, Bin; Wu, Jianmin; Kong, Weiyao; Song, Guohong; Jiang, Hanfang; Wang, Jing; Wan, Fengling.
Afiliação
  • Liu X; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of breast oncology, Peking University Cancer Hospital & Institute, Fucheng Road No.52, Haidian District, Beijing, 100142, China.
  • Li H; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of breast oncology, Peking University Cancer Hospital & Institute, Fucheng Road No.52, Haidian District, Beijing, 100142, China.
  • Shao B; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of breast oncology, Peking University Cancer Hospital & Institute, Fucheng Road No.52, Haidian District, Beijing, 100142, China.
  • Wu J; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of breast oncology, Peking University Cancer Hospital & Institute, Fucheng Road No.52, Haidian District, Beijing, 100142, China.
  • Kong W; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of breast oncology, Peking University Cancer Hospital & Institute, Fucheng Road No.52, Haidian District, Beijing, 100142, China.
  • Song G; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of breast oncology, Peking University Cancer Hospital & Institute, Fucheng Road No.52, Haidian District, Beijing, 100142, China.
  • Jiang H; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of breast oncology, Peking University Cancer Hospital & Institute, Fucheng Road No.52, Haidian District, Beijing, 100142, China.
  • Wang J; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of breast oncology, Peking University Cancer Hospital & Institute, Fucheng Road No.52, Haidian District, Beijing, 100142, China.
  • Wan F; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of breast oncology, Peking University Cancer Hospital & Institute, Fucheng Road No.52, Haidian District, Beijing, 100142, China.
Cancer Med ; 6(3): 547-554, 2017 03.
Article em En | MEDLINE | ID: mdl-28135048
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mutação em Linhagem Germinativa / Proteína BRCA1 / Polimorfismo de Nucleotídeo Único / Povo Asiático / Neoplasias de Mama Triplo Negativas Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Cancer Med Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mutação em Linhagem Germinativa / Proteína BRCA1 / Polimorfismo de Nucleotídeo Único / Povo Asiático / Neoplasias de Mama Triplo Negativas Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Cancer Med Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos